Cover Image
市場調查報告書

TaiMed Biologics Inc. 的產品平台分析

TaiMed Biologics Inc. - Product Pipeline Review - 2015

出版商 Global Markets Direct 商品編碼 293998
出版日期 內容資訊 英文 27 Pages
訂單完成後即時交付
價格
Back to Top
TaiMed Biologics Inc. 的產品平台分析 TaiMed Biologics Inc. - Product Pipeline Review - 2015
出版日期: 2015年11月18日 內容資訊: 英文 27 Pages
簡介

TaiMed Biologics Inc. 是總公司在台灣的生物科技企業,藥物研發、開發、參與流通病毒性感染疾病的預防及治療的新醫藥品。開發中產品有AIDS病毒侵入抑制劑的TMB-355,及抑制流感病毒、神經胺糖酸酶的低分子治療藥TMB-571等。

本報告提供TaiMed Biologics Inc. 的治療藥開發平台的現狀及各開發階段比較分析、各藥物標的、作用機制、給藥途徑、分子類型的治療藥的評估、最新的企業新聞和發表、後期階段及中止的計劃相關資訊等。

目錄

TaiMed Biologics Inc. 的基本資料

  • TaiMed Biologics Inc. 概要
  • 主要資訊
  • 企業資料

TaiMed Biologics Inc. :R&D概要

  • 主要的治療範圍

TaiMed Biologics Inc. :開發平台的檢討

  • 各開發階段的開發中產品
  • 單劑產品

TaiMed Biologics Inc. :開發中產品概況

  • 臨床階段的開發中產品
    • 第二階段的產品/聯合治療模式
    • 第一階段的產品/聯合治療模式
  • 初期階段的開發中產品
    • 前臨床階段的產品/聯合治療模式

TaiMed Biologics Inc. :藥物簡介

  • ibalizumab
  • Drugs to Inhibit Integrase for HIV
  • ibalizumab second generation
  • TMB-571
  • TMB-607
  • TMB-657

TaiMed Biologics Inc. :開發平台分析

  • 各標靶
  • 各給藥途徑
  • 各分子類型
  • 各作用機制

TaiMed Biologics Inc. :最新的開發平台資訊

TaiMed Biologics Inc. :現在暫停中的計劃

TaiMed Biologics Inc. :總公司和子公司的所在地

  • 總公司

附錄

圖表一覽

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GMDHC07759CDB

Summary

Global Markets Direct's, 'TaiMed Biologics Inc. - Product Pipeline Review - 2015', provides an overview of the TaiMed Biologics Inc.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of TaiMed Biologics Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of TaiMed Biologics Inc. including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of TaiMed Biologics Inc.'s human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the TaiMed Biologics Inc.'s pipeline products

Reasons to buy

  • Evaluate TaiMed Biologics Inc.'s strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of TaiMed Biologics Inc. in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the TaiMed Biologics Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of TaiMed Biologics Inc. and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of TaiMed Biologics Inc.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of TaiMed Biologics Inc. and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • TaiMed Biologics Inc. Snapshot
    • TaiMed Biologics Inc. Overview
    • Key Information
    • Key Facts
  • TaiMed Biologics Inc. - Research and Development Overview
    • Key Therapeutic Areas
  • TaiMed Biologics Inc. - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
  • TaiMed Biologics Inc. - Pipeline Products Glance
    • TaiMed Biologics Inc. - Late Stage Pipeline Products
      • Phase III Products/Combination Treatment Modalities
    • TaiMed Biologics Inc. - Clinical Stage Pipeline Products
      • Phase I Products/Combination Treatment Modalities
    • TaiMed Biologics Inc. - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
  • TaiMed Biologics Inc. - Drug Profiles
    • ibalizumab
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Small Molecule to Inhibit Integrase for HIV
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • TMB-571
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • TMB-607
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • TMB-657
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • TaiMed Biologics Inc. - Pipeline Analysis
    • TaiMed Biologics Inc. - Pipeline Products by Target
    • TaiMed Biologics Inc. - Pipeline Products by Route of Administration
    • TaiMed Biologics Inc. - Pipeline Products by Molecule Type
    • TaiMed Biologics Inc. - Pipeline Products by Mechanism of Action
  • TaiMed Biologics Inc. - Recent Pipeline Updates
  • TaiMed Biologics Inc. - Dormant Projects
  • TaiMed Biologics Inc. - Locations And Subsidiaries
    • Head Office
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • TaiMed Biologics Inc., Key Information
  • TaiMed Biologics Inc., Key Facts
  • TaiMed Biologics Inc. - Pipeline by Indication, 2015
  • TaiMed Biologics Inc. - Pipeline by Stage of Development, 2015
  • TaiMed Biologics Inc. - Monotherapy Products in Pipeline, 2015
  • TaiMed Biologics Inc. - Phase III, 2015
  • TaiMed Biologics Inc. - Phase I, 2015
  • TaiMed Biologics Inc. - Preclinical, 2015
  • TaiMed Biologics Inc. - Pipeline by Target, 2015
  • TaiMed Biologics Inc. - Pipeline by Route of Administration, 2015
  • TaiMed Biologics Inc. - Pipeline by Molecule Type, 2015
  • TaiMed Biologics Inc. - Pipeline Products by Mechanism of Action, 2015
  • TaiMed Biologics Inc. - Recent Pipeline Updates, 2015
  • TaiMed Biologics Inc. - Dormant Developmental Projects,2015

List of Figures

  • TaiMed Biologics Inc. - Pipeline by Top 10 Indication, 2015
  • TaiMed Biologics Inc. - Pipeline by Stage of Development, 2015
  • TaiMed Biologics Inc. - Monotherapy Products in Pipeline, 2015
  • TaiMed Biologics Inc. - Pipeline by Top 10 Target, 2015
  • TaiMed Biologics Inc. - Pipeline by Top 10 Route of Administration, 2015
  • TaiMed Biologics Inc. - Pipeline by Top 10 Molecule Type, 2015
  • TaiMed Biologics Inc. - Pipeline Products by Top 10 Mechanism of Action, 2015
Back to Top